QTTB
QTTB
NASDAQ · Biotechnology

Q32 Bio Inc

$15.37
-0.04 (-0.26%)
As of Aug 15, 2:23 AM ET ·
Analyst Consensus
Strong Buy
11
Analysts
Moderate
Coverage
Buy 9 82%
Hold 2 18%
Sell 0 0%
Price Target
Analyst Price Target +81.8% upside
Low Target $24.18
Average Target $27.94
High Target $39.76
Current Price $15.37
Current
$15.37
Target
$27.94
$24.18 $27.94 avg $39.76
Scenario Analysis
Bear Case
$24.18
57.3%
Low target
Base Case
$27.94
+81.8%
Avg target
Bull Case
$39.76
+158.7%
High target
Risk/Reward
2.8x
Favorable
Price in Context
52-Week High
$23.57
-34.8% from high
52-Week Low
$1.62
+848.8% from low
Target vs 52W High
$27.94
+18.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 38 82% $257.58 +3.3%
AMGN
Amgen Inc
Hold 43 49% $190.87 -54.0%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.1%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 37 81% $438.34 -13.3%
REGN
Regeneron Pharmaceuticals
Buy 37 70% $76.80 -90.4%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -53.9%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -44.0%
BIIB
Biogen Inc
Buy 43 67% $91.45 -56.4%